Deadline to save $900:
- 00Days
- 00Hrs
- 00Mins
- 00Secs
Monday, March 17th, 2025 — Pre-Conference Workshops - EST/EDT (Eastern Daylight, GMT-4)
Strategize on best practices in collaborating with hospital systems and research organizations to advance access and treatment development
Uncover specific challenges and success stories in funding clinical trials and research through a consortium of pediatric hospitals across the country
Learn more about the TORCH initiative, its $2 million annual funding goal and how it is creating innovation at both the hospital and local level
- Erin Santos Primis - President, Isabella Santos Foundation
- Daniel DeFabio - Director, Community Engagement, Global Genes
This session explores the rise of AFPs and specialty carve-outs, analyzing how these programs affect the pharmaceutical landscape, patient affordability and access to specialty medications. Discuss the legal, regulatory and financial ramifications, offering strategies for pharmaceutical companies to challenge these programs and protect market share.
- Jonathan James - Chief Executive Officer, Hope Charities
Explore how pharma can utilize EHR systems to gain deeper market insights, streamline payer negotiations and enhance real-world evidence for drug access strategies
Leverage EHR data to support reimbursement, improve formulary positioning and foster collaborations with healthcare providers for better commercial outcomes
Foster stronger collaboration between pharma and payers to eliminate redundancies, reduce administrative burdens and enhance the efficiency of patient navigation
Evaluate a unified digital health approach to improve adherence, streamline communication and ensure quicker access to therapies, ultimately driving better patient outcomes
Break down barriers between pharma, payers and healthcare providers, creating a frictionless experience that accelerates treatment access and improves the patient journey from diagnosis to therapy
Discuss working with ambassador programs, engagement campaigns and efforts to increase community involvement
Establish strong advocate networks and create communication strategies that resonate with communities
Understand how to balance long-term planning with need for nimble, real-time response to critical issues
- Michele Guadalupe - Director of Advocacy and Access, National Eczema Association
As AFPs increasingly divert patients away from traditional coverage models, pharmaceutical companies must develop strategies to safeguard patient access to essential treatments. This session focuses on building robust patient assistance programs, collaborating with payers and ensuring compliance, while addressing the challenges posed by specialty carve-outs, including how AFPs are evolving their business models and tactics based on observations.
- Liz Austin - Patient Foundation Head, Genentech
**Attendee qualification and approval for this session is at the discretion of Informa Connect.
Capitalize on EHR data to refine their commercial strategies and optimize market entry and expansion efforts
Focus on how integrating EHR insights into market access planning can help forecast demand, identify treatment gaps and provide data-driven support for pricing, contracting and distribution strategies
- Robert Britting - Senior Director, US Customer Marketing, Vaccines Franchise, GSK